Thread regarding Catalyst Pharmaceuticals Partners (CPRX)

I can't understand why this stock is not much, much higher. The company has seen its revenue increase by a whopping 7,000 percent in the last two years (I didn't accidentally add a zero there) since they got Firdapse on the market. Another version of the dr-g is being worked on and the use of the current one is being expanded to more groups. The company's future looks good. Better than good. How its stock is not reflecting that, is beyond me.